Trademark Search  /  SYMPHORNA

SYMPHORNA

● Live · Registered

U.S. federal trademark · Serial No. 99379564 · Reg. No. UK00004245393

Mark
SYMPHORNA
Status
Registered
Serial Number
99379564
Registration No.
UK00004245393
Filing Date
August 6, 2025
Registration Date
October 24, 2025
Class(es)
Class 001, Class 005, Class 009, Class 010, Class 035, Class 040, Class 042

Owners

Uncommon Bio Limited
99 · Cambridge, GB
Uncommon Bio Limited
99 · Cambridge, GB
Uncommon Bio Limited
99 · Cambridge, GB

Goods & Services

Chemical substances and organic compounds for the manufacture of pharmaceuticals and dietary supplements and for use in the biotechnology industry, namely nucleotides, nucleosides, and enzymes for use in nucleic acid synthesis; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; preservatives for use in the pharmaceutical and food industries; nucleic acids, RNA, and mRNA for laboratory use, namely synthetic mRNA constructs and small interfering RNA (siRNA) molecules; plasmids and gene vectors for research purposes; lipids and lipid-based substances for use in drug delivery systems; biologically active molecules for use in biotechnology; biochemical catalysts; culture media and reagents for growing cells and tissues in laboratory conditions, namely cell culture media, buffers, and growth reagents; plant extracts for use in the manufacture of pharmaceuticals, dietary supplements and in the biotechnology industry; vitamins, minerals, and proteins for use in food and supplement manufacture; lipids and lipid-based formulations for industrial use in pharmaceutical and biotechnological manufacturing; fatty substances and carrier compounds for use in the production of therapeutic and nutritional products, namely lipid nanoparticles and polymer-based carrier compounds; lipids for use in the manufacture of pharmaceuticals, dietary supplements and in the biotechnology industry

Sanitary preparations for medical use; RNA-based vaccines; therapeutic vaccines; oligonucleotide-based therapeutics, namely antisense oligonucleotide therapeutics; gene therapy preparations, namely viral vector-based gene therapy preparations; CRISPR-based therapeutics and genome editing agents, namely CRISPR-Cas9 gene editing preparations; immunotherapeutic agents, namely monoclonal antibody-based immunotherapeutic agents; therapeutic preparations for modulation of immune responses; personalised medicine formulations, namely patient-specific RNA-based therapeutic formulations; cell-based pharmaceutical preparations, namely engineered cell therapy preparations; in vivo cell therapy preparations in the form of pharmaceutical compositions, namely in vivo reprogrammed cell therapy compositions; ex vivo cell therapy preparations in the form of pharmaceutical compositions comprising modified or unmodified cells for administration to patients; regenerative and tissue-based therapeutic products, namely tissue regeneration formulations for organ repair; pharmaceutical preparations incorporating lipid nanoparticles or other delivery systems, namely lipid nanoparticle-encapsulated RNA therapeutics; diagnostic reagents and test kits comprising antibodies, primers, and detection reagents for medical use; diagnostic preparations for veterinary purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements; nutritional supplements; biological and pharmaceutical preparations for medical and veterinary use, namely RNA-based veterinary therapeutics

Custom manufacture of pharmaceuticals, biopharmaceuticals, gene therapy products, dietary supplements, and therapeutic delivery systems; manufacturing of personalised medicine products; contract manufacturing of therapeutics, supplements, and RNA delivery platforms

Downloadable software and mobile applications for use in the design, analysis, modelling, or optimisation of nucleic acid sequences, including RNA-based therapeutics; downloadable computer software for use in therapeutic delivery system design; downloadable computer software for bioinformatics, genetic analysis, and molecular diagnostics; downloadable databases and data management tools for drug discovery and personalised medicine; downloadable machine learning software for identifying and predicting therapeutic targets, molecular interactions, or genetic biomarkers; downloadable artificial intelligence software for bioinformatics, genetic analysis, and drug discovery; downloadable computer software for use in pharmaceutical research, formulation design, and RNA delivery platform development

Retail and wholesale store services featuring pharmaceuticals, biopharmaceuticals, dietary and nutritional supplements, medical devices, chemical substances and organic compounds for biotechnology and pharmaceutical use, laboratory reagents, diagnostic test kits, lipids and lipid-based formulations, plant-based supplements, vitamins, minerals, and other nutraceuticals; online retail store services in the field of biotechnology, diagnostics, and healthcare products featuring pharmaceutical and biotechnology products; retail store services featuring RNA-based therapeutics, delivery systems, and oligonucleotide products, namely mRNA and siRNA therapeutic products

Scientific and technological research in the fields of pharmaceuticals, biotechnology, and healthcare; pharmaceutical and biopharmaceutical research and development; development of mRNA-based therapeutics and vaccines; genetic and molecular biology research; scientific laboratory services for research and development in the fields of pharmaceuticals, biotechnology, and healthcare; laboratory testing and analysis; bioinformatics and computational biology, namely sequence alignment and genomic data analysis software services; AI-based drug discovery services, namely machine learning-based target identification services; genetic profiling for therapeutic purposes; design and testing of drug delivery systems and personalised medicine platforms; industrial research in the fields of pharmaceuticals, biotechnology, and healthcare; quality control of goods and services; technological consultancy in complex scientific fields, namely biotechnology and pharmaceutical development; consultancy pertaining to pharmacology and biotechnology; product research and development of dietary supplements and nutraceuticals; software as a service (SaaS) and platform services for the design, modelling, or optimisation of RNA sequences, delivery technologies, and therapeutic formulations; providing temporary use of online, non-downloadable computer software for use in therapeutic delivery system design; providing temporary use of online, non-downloadable computer software for bioinformatics, genetic analysis, and molecular diagnostics; providing temporary use of online, non-downloadable computer software for use in pharmaceutical research, formulation design, and RNA delivery platform development; processing and synthesis of nucleic acids, including mRNA and DNA, namely DNA and RNA screening services for scientific research purposes; research and development of biological substances and reagents; research and development of lipid and polymer-based drug delivery systems; research and development of organic substances, lipids, polymers, and excipients at the request of third parties; research and development of synthetic genes, oligonucleotides, chemically modified RNAs, polymer conjugates, and lipid-polymer complexes

Medical and diagnostic apparatus and instruments, namely biosensor-based diagnostic devices; injectors and drug delivery devices, namely needle-free injectors and autoinjector pens; wearable and implantable medical devices for administering pharmaceutical or gene therapy preparations; microneedle patches; transfection devices, namely electroporation-based transfection devices; medical diagnostic test kits for clinical and laboratory use, namely home-use test kits for blood glucose monitoring; apparatus for RNA-based therapeutic delivery, namely microneedle patch delivery apparatus; devices for personalised medicine and genetic diagnostics, namely genetic sequencing devices for personalised treatment planning; medical apparatus incorporating biosensors, nucleic acid detection systems, or AI-based diagnostic components, namely nucleic acid detection biosensor devices; devices for nucleic acid transfection and RNA delivery, namely lipid nanoparticle-based RNA delivery devices

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "SYMPHORNA" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.